Insider trading

Period: 120 months Stock: SPRY Minimum amount: $100K × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

121 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

121 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

121 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

121 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
121 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
121 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

121 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
12 Jun 2026
Karas Eric Chief Commercial Officer
Sold on a plan
$250.00K 25,000 at 10.00
67.2%
Sold half or more
13 Nov 2025
Dorsey Brian Chief Operating Officer
Sold at will
$190.05K 21,828 at 8.71
66.9%
Sold half or more
12 Nov 2025
Chakma Justin Chief Business Officer
Sold at will 2×
$1.48M 166,380 at 8.87
100%
Sold half or more
21 Aug 2025
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan
$724.35K 50,000 at 14.49
4.0%
Planned (10b5-1)
21 Aug 2025
Scott Kathleen D. Chief Financial Officer
Sold on a plan
$187.50K 12,500 at 15.00
55.5%
Sold half or more
20 Aug 2025
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan
$530.63K 37,656 at 14.09
2.9%
Planned (10b5-1)
19 Aug 2025
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan
$173.13K 12,344 at 14.03
1.0%
Planned (10b5-1)
1 Jul 2025
Karas Eric Chief Commercial Officer
Sold on a plan
$254.86K 15,000 at 16.99
59.3%
Sold half or more
27 Jun 2025
Flynn James E 10% owner · indirect
Sold at will 2×
$13.66M 740,149 at 18.46
13.2%
Not planned
18 Jun 2025
Karas Eric Chief Commercial Officer
Sold on a plan
$240.00K 15,000 at 16.00
66.1%
Sold half or more
20 May 2025
SAUNDERS BRENT L Director
Sold at will
$1.71M 120,000 at 14.25
100%
Sold half or more
20 May 2025
Fitzpatrick Alexander A Chief Legal Officer
Sold at will
$1.45M 102,969 at 14.10
53.5%
Sold half or more
20 May 2025
Scott Kathleen D. Chief Financial Officer
Sold at will
$705.17K 50,000 at 14.10
87.1%
Sold half or more
7 Apr 2025
Shawver Laura Director
Sold on a plan
$615.07K 50,002 at 12.30
19.2%
Planned (10b5-1)
20 Mar 2025
Karas Eric Chief Commercial Officer
Sold on a plan
$140.00K 10,000 at 14.00
56.5%
Sold half or more
6 Mar 2025
Shawver Laura Director
Sold on a plan
$556.05K 49,600 at 11.21
19.1%
Planned (10b5-1)
3 Feb 2025
Shawver Laura Director
Sold on a plan
$615.57K 50,000 at 12.31
19.2%
Planned (10b5-1)
6 Jan 2025
Shawver Laura Director
Sold on a plan
$555.07K 50,000 at 11.10
19.2%
Planned (10b5-1)
17 Dec 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$1.17M 100,000 at 11.67
8.3%
Planned (10b5-1)
17 Dec 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$1.17M 100,000 at 11.67
8.3%
Planned (10b5-1)
13 Dec 2024
Chakma Justin Chief Business Officer
Sold at will
$328.97K 27,272 at 12.06
16.7%
Not planned
12 Dec 2024
Chakma Justin Chief Business Officer
Sold at will
$1.44M 117,333 at 12.27
46.2%
Not planned
12 Dec 2024
Dorsey Brian Chief Operating Officer
Sold on a plan
$307.43K 25,000 at 12.30
80.6%
Sold half or more
11 Dec 2024
Dorsey Brian Chief Operating Officer
Sold on a plan
$186.43K 15,000 at 12.43
71.3%
Sold half or more
10 Dec 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$1.32M 100,000 at 13.16
8.0%
Planned (10b5-1)
10 Dec 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$1.32M 100,000 at 13.16
8.0%
Planned (10b5-1)
10 Dec 2024
Chakma Justin Chief Business Officer
Sold at will
$657.63K 50,000 at 13.15
26.8%
Not planned
6 Dec 2024
Chakma Justin Chief Business Officer
Sold at will
$711.62K 50,000 at 14.23
26.8%
Not planned
5 Dec 2024
Chakma Justin Chief Business Officer
Sold at will
$701.64K 49,640 at 14.13
26.7%
Not planned
4 Dec 2024
Chakma Justin Chief Business Officer
Sold at will
$627.94K 45,000 at 13.95
24.8%
Not planned
4 Dec 2024
Shawver Laura Director
Sold on a plan
$203.11K 14,772 at 13.75
6.6%
Planned (10b5-1)
3 Dec 2024
Shawver Laura Director
Sold on a plan
$1.17M 87,984 at 13.26
29.5%
Planned (10b5-1)
3 Dec 2024
Chakma Justin Chief Business Officer
Sold at will
$593.40K 45,000 at 13.19
24.8%
Not planned
2 Dec 2024
Shawver Laura Director
Sold on a plan 2×
$1.32M 97,244 at 13.56
31.6%
Planned (10b5-1)
2 Dec 2024
Chakma Justin Chief Business Officer
Sold at will
$615.22K 45,000 at 13.67
24.8%
Not planned
27 Nov 2024
Chakma Justin Chief Business Officer
Sold at will
$359.75K 25,000 at 14.39
15.5%
Not planned
26 Nov 2024
Chakma Justin Chief Business Officer
Sold at will
$592.57K 42,186 at 14.05
20.7%
Not planned
25 Nov 2024
Chakma Justin Chief Business Officer
Sold at will
$459.42K 32,814 at 14.00
13.9%
Not planned
19 Nov 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$1.39M 100,000 at 13.95
7.7%
Planned (10b5-1)
19 Nov 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$1.39M 100,000 at 13.95
7.7%
Planned (10b5-1)
12 Nov 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 4×
$1.68M 100,000 at 16.85
7.4%
Planned (10b5-1)
12 Nov 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 4×
$1.68M 100,000 at 16.85
7.4%
Planned (10b5-1)
12 Nov 2024
Flynn James E 10% owner · indirect
Sold at will 4×
$609.06K 34,814 at 17.49
0.7%
Not planned
11 Nov 2024
Flynn James E 10% owner · indirect
Sold at will 4×
$9.53M 528,456 at 18.04
9.1%
Not planned
16 Oct 2024
Scott Kathleen D. Chief Financial Officer
Sold on a plan
$200.00K 12,500 at 16.00
71.6%
Sold half or more
15 Oct 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 3×
$1.49M 100,000 at 14.88
7.2%
Planned (10b5-1)
15 Oct 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 3×
$1.49M 100,000 at 14.88
7.2%
Planned (10b5-1)
8 Oct 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$1.38M 100,000 at 13.83
6.9%
Planned (10b5-1)
8 Oct 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$1.38M 100,000 at 13.83
6.9%
Planned (10b5-1)
18 Sep 2024
Karas Eric Chief Commercial Officer
Sold on a plan
$140.00K 10,000 at 14.00
63.7%
Sold half or more
Showing 1–50 of 121. Page 1 of 3 Older →